Product
Short acting beta agonist (SABA)
1 clinical trial
1 indication
Indication
AsthmaClinical trial
A Two-part Phase IIa Randomised, Double-blind, Placebo-controlled, Dose-ranging, Multi-centre Study to Assess Efficacy and Safety of Inhaled AZD1402 Administered as a Dry Powder for Four Weeks in Adults With Asthma on Medium-to-High Dose Inhaled CorticosteroidsStatus: Terminated, Estimated PCD: 2023-07-20